Investing In CME Group Inc (NASDAQ: CME): Why Should You?

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Recently, Yahoo Finance discussed the stock, revealing that Copper Option Open Interest Surpasses 200,000 for the First Time Ever.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

As a NASDAQ listed company, CME falls under the Financial sector while operating within the Financial Data & Stock Exchanges industry segment. The current market capitalization of CME Group Inc is $77.62B. A total of 1.81 million shares were traded on the day, compared to an average of 1.77M shares.

In the most recent transaction, SHEPARD WILLIAM R bought 282 shares of CME for 214.71 per share on Mar 26 ’24. After the transaction, the Director now owns 253,343 company shares. In a previous transaction on Mar 26 ’24, SHEPARD WILLIAM R bought 12 shares at 214.71 per share. CME shares that Director owns now total 2,334.

Among the insiders who sold shares, McCourt Timothy Francis disposed of 35 shares on Jan 31 ’24 at a per-share price of $206.78. This resulted in the Sr MD Global Head Equity & FX holding 6,447 shares of CME after the transaction. In another insider transaction, SHEPARD WILLIAM R bought 1,331 shares at $202.44 per share on Jan 18 ’24. Company shares held by the Director now total 253,060.

Dividend

Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. CME Group Inc pays an annual dividend of $4.45, resulting in a dividend yield of 2.06%, and it has a price to earnings (P/E) ratio of 24.33. CME’s most recent ex-dividend date was 3/7/2024 when it declared a $1.15 quarterly dividend that was paid in cash on 3/26/2024. Previously, the company paid the dividend on 1/18/2024 with an ex-dividend date of 12/27/2023. The CME stock dividend was $5.25 per share in cash.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CME has a high of $222.63 and a low of $171.43.

As of this writing, CME has an earnings estimate of $2.45 per share for the current quarter. EPS was calculated based on a consensus of 14 estimates, with a high estimate of $2.55 per share and a lower estimate of $2.35. The company reported an EPS of $2.25 in the last quarter, which was 1.40% higher than expectations of $2.22.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CME’s latest balance sheet shows that the firm has $2.95B in Cash & Short Term Investments as of fiscal 2021. There were $3.45B in debt and $160.40B in liabilities at the time. Its Book Value Per Share was $74.43, while its Total Shareholder’s Equity was $27.40B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CME is Buy with a score of 3.75.

Most Popular

Related Posts